DD vs HCAT · P/E 127, rev $12.39B vs rev $306.6M
Dupont De Nemours Inc (DD) versus Health Catalyst Inc (HCAT) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Health Catalyst Inc (HCAT) is a health information services company listed on NASDAQ.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported HCAT revenue for 2024-12-31 was $306.6M. Net income was -$69.5M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. HCAT currently screens at market cap $130.8M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. HCAT currently screens at market cap $130.8M.
Not investment advice. Open the DD and HCAT stock pages for the full models.
Not investment advice.